The news directly pertains to Genpact (NYSE:G) as the analyst from Wedbush has reiterated a Neutral rating and maintained a $45 price target. This suggests that the analyst sees the stock as fairly valued at its current price, which could lead to a neutral short-term impact on the stock price.